How many distributors does Pfizer have?
28,000 global manufacturing and distribution colleagues. Supplying medicines and vaccines to 181 countries. Delivering more than 25 billion doses every year.
The largest manufacturing site in the Pfizer network is located in Kalamazoo, Michigan. This 1,300 acre facility manufactures active pharmaceutical ingredients (API), drug products (DP) and medical devices.
Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies.
It distributes about 65 drugs in the United States. GlaxoSmithKline has more than 80 manufacturing sites including in the U.K., the U.S., and Asia.
Our distribution is built on a flexible just-in-time system which will ship the frozen vials to the point of vaccination. The intent is to utilize Pfizer-strategic transportation partners to ship by air to major hubs within a country/region and by ground transport to dosing locations.
- Identify business need; conduct pre-project planning; review applicable supplier diversity registrations.
- Form cross-functional team and define project.
Building up Pfizer's existing manufacturing facilities
As research and development teams focused on testing different vaccine candidates, two of Pfizer's largest plants — located in Kalamazoo, Michigan and Puurs, Belgium — set aside space and, together, engineered a process to safely manufacture the vaccine.
Karikó and co-collaborator Drew Weissman, MD, PhD, invented the modified mRNA technology used in Pfizer-BioNTech and Moderna's vaccines to prevent COVID-19 infection.
Drugs Associated with Pfizer Inc.
|azithromycin Generic Drug class: macrolides||1155 reviews||6.9 / 10|
Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare | Johnson & Johnson.
Who are Pfizer's buyers?
Competition Bureau approves Pharmascience as buyer of Pfizer products.
“We are excited to add the impressive experience and pipeline of Arena Pharmaceuticals to Pfizer's Inflammation and Immunology therapeutic area, helping us further our purpose of developing breakthroughs to change the lives of those with immuno-inflammatory diseases,” said Mike Gladstone, Global President & General ...